DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Champagne MA, Fu CH, Chang M et al.
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children’s Oncology Group.
Pediatr Blood Cancer 2011;
57: 56-62
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.